Fake Cancer Drugs: Kumar Pleads Guilty

HOUSTON, TX – A brazen scheme to peddle fake cancer medication has landed Sanjay Kumar, a 45-year-old Indian national, in federal court. Kumar pleaded guilty today to conspiring to sell and ship counterfeit oncology pharmaceuticals into the United States, a scheme that preyed on the desperation of cancer patients and their families.

The fraud spanned from August 2018 to June 2024, with Kumar and his associates trafficking counterfeit versions of Keytruda, a critical immunotherapy drug used to treat melanoma, Hodgkin lymphoma, and several other cancers. The operation raked in tens of thousands of dollars, capitalizing on the high cost and demand for this life-saving medication. Only Merck Sharp & Dohme LLC is authorized to manufacture genuine Keytruda.

But the drugs Kumar sold weren’t medicine at all. Investigators discovered the counterfeit Keytruda bore fake trademarks and, crucially, contained no active ingredient. Instead, the vials were filled with worthless fillers and adulterants – essentially, placebos disguised as a potentially life-extending treatment. The packaging was meticulously copied, almost indistinguishable from the legitimate product, designed to deceive both patients and healthcare professionals.

Federal investigators caught Kumar red-handed during an undercover operation. He attempted to sell further quantities of the fake drugs, and chillingly admitted he knew they were useless. According to court records, Kumar described the counterfeit Keytruda as “just like water,” a callous admission revealing his complete disregard for the health and well-being of those he defrauded.

The case, delayed in publication due to a recent government shutdown, is now moving towards sentencing. U.S. District Judge Lee H. Rosenthal will hand down Kumar’s sentence on January 13th. He faces a potential maximum of 20 years in federal prison and a hefty $250,000 fine. The investigation was a joint effort by Immigration and Customs Enforcement – Homeland Security Investigations and the Food and Drug Administration.

Assistant U.S. Attorney Jay Hileman, alongside Trial Attorneys Ethan Cantor, Bryce Rosenbower and Jeff Pearlman of the Computer Crime and Intellectual Property Section, are prosecuting the case. This conviction sends a clear message: those who profit from the suffering of others, particularly by peddling fake cures, will be brought to justice. The Grimy Times will continue to follow this case and report on the sentencing.